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Abstract
Background: Bluetongue virus (BTV) infection causes haemorrhagic disease in ruminants and induces cell death.
The pathogenesis in animals and in cell culture has been linked to BTV-induced apoptosis.
Results: In this report, we investigated BTV-induced apoptosis in cell culture in depth and show that both extrinsic
(caspase-8 activation) and intrinsic (caspase-9 activation) pathways play roles in BTV apoptosis. Further, by using
chemical inhibitors and knock-out cell lines, we show that these pathways act independently of each other in BTV
infected cells. In addition to activation of caspase-8, -9 and executioner caspase-3, we also identified that BTV
infection causes the activation of caspase-7, which results in the cleavage of poly (ADP-ribose) polymerase (PARP).
BTV-induced cell death appears to be due to apoptosis rather than necrosis, as the HMBG-1 was not translocated
from the nucleus. We also examined if NF-B response is related to BTV-induced apoptosis as in reovirus. Our data
suggests that NF-B response is not linked to the induction of apoptosis. It is controlled by the degradation of
only IBa but not IBb, resulting in a rapid transient response during BTV infection. This was supported using an
NF-B dependent luciferase reporter gene assay, which demonstrated early response, that appeared to be
suppressed by the late stage of BTV replication. Furthermore, virus titres were higher in the presence of NF-B
inhibitor (SN50), indicating that NF-B has a role in initiating an antiviral environment. In addition, we show that
BTV infection induces the translocation of interferon regulatory factors (IRF-3 and IRF-7) into the nucleus. The
induction of IRF responses, when measured by IRF dependent luciferase reporter gene assay, revealed that the IRF
responses, like NF-B response, were also at early stage of infection and mirrored the timing of NF-B induction.
Conclusion: BTV triggers a wide range of caspase activities resulting in cell apoptosis. Although both NF-B and
IRF responses are induced by BTV infection, they are not sustained.
Introduction
Bluetongue (BT) is a haemorrhagic disease of ruminants,
which is caused by Bluetongue virus (BTV), a member
of the orbivirus genus within the family Reoviridae. BTV
consists of seven structural proteins (VP1 - VP7) orga-
nised in a double-capsid structure. Two of the seven
proteins (VP2, VP5) make up the outer capsid of the
virus and the remaining five proteins (VP1, VP3, VP4,
VP6 and VP7) are located in the inner capsid or core
together with the double-stranded RNA genome consist-
ing of ten segments. Three non-structural proteins that
are not associated with the virion are also expressed
(NS1-3) in the infected cells. To date, 24 different sero-
types have been officially recognised and an additional
serotype has recently been identified by sequence analy-
sis [1,2]. BTV is an insect-borne virus, which is trans-
mitted from animal to animal by blood feeding midges
(Culicoides spps) and has been endemic mainly in tropi-
cal and sub-tropical countries. Although BTV infects a
wide variety of domestic and wild ruminants, classically,
BT is considered predominantly as a sheep disease and
indeed BTV infection in certain breeds of sheep may
cause severe morbidity and high mortality. In recent
years, BTV has emerged in northern Europe and re-
emerged in the Mediterranean basin causing severe dis-
ease and high mortality in naïve ruminant populations.
Outbreaks have affected not only sheep, but also other
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livestock such as cattle and goats [3,4]. The clinical
symptoms of BTV infection are thought to be associated
with virus-induced vascular injury and endothelial cell-
derived inflammatory responses [5-8] and apoptosis [9],
although host responses at a cellular level that result in
the pathogenesis caused by BTV infection have not been
investigated thoroughly.
BTV induces apoptosis both in cultured cells and in
target tissues in vivo and one current hypothesis is that
apoptosis plays a major role in the pathogenesis of BTV
infection [10-12]. Virus infected cells that undergo apop-
tosis show highly characteristic morphological changes,
including shrinkage, blebbing of the plasma membrane,
chromatin condensation and DNA fragmentation. In a
previous report, we showed that extracellular treatment
with a combination of both the cellular receptor binding
protein VP2 and the cell penetration protein VP5, is suf-
ficient to trigger apoptosis through the activation of
executioner caspase-3 [11]. Subsequent to this report,
others have reported that both the extrinsic and intrinsic
pathways are involved in the induction of apoptosis by
BTV [9,10,12]. However, the results in these reports have
contradictory conclusions, particularly in relation to cas-
pase-8 activation. While Li et al. [10] reported that BTV
infection does not cause caspase-8 cleavage [10], a subse-
quent publication by others presented the cleavage data
of caspase-8 [12]. Further, the interrelationship between
the intrinsic and extrinsic pathways in triggering apopto-
sis has not been investigated.
Previously, we have also identified the translocation of
NF-B into the nucleus from cytoplasm during BTV
infection of mammalian cells and we had postulated,
based on the finding with reovirus [13] that NF-B acti-
vation by BTV infection was involved in induction of
cellular apoptosis [11]. Activation of NF-B by a viral
infection promotes the expression of a variety of genes
that are involved either in regulating the host survival
immune responses or in apoptosis. However, certain
virus infection such as African swine fever virus inhibits
NF-B activation, which results in enhancement of virus
replication and thereby contributing to virus-induced
pathogenesis [14].
Activation of NF-B is generally a rapid response to
an inducer, including virus infection [15]. The NF-B
exists as a heterodimer which is sequestered in the cyto-
sol of unstimulated cells via non-covalent interactions
with a class of inhibitor proteins, called IBs (viz., IBa,
b, g etc; [16]). These inhibitor proteins mask the nuclear
localisation signal of NF-B. Signals that induce NF-B
activity cause the phosphorylation of IBs, their disso-
ciation and subsequent degradation, allowing NF-B
proteins to enter the nucleus and induce gene expres-
sion. The specific phophorylation and degradation of the
IBs determines whether the activation of NF-B is a
rapid and transient response. In this report, we investi-
gated the activation and role of NF-B during BTV
infection, demonstrating that it has a role in initiating
an antiviral environment as a part of the innate immune
response.
Another mechanism of the innate immune system in
response to virus infection is the activation of interferon
regulatory factors (IRF) that results in the secretion of
antiviral cytokines, particularly, interferon (IFN). Since
BTV induces strong cytokine responses, BTV may also
trigger innate immune pathways via IRF that are respon-
sible for regulating cytokine production [17-19]. In parti-
cular, IRF-3 is ubiquitously expressed and accumulates in
the cytosol to enable a rapid response to viral infection
and up-regulate the type 1 IRF [18]. Although the induc-
tion of IRF in the other members of the family Reoviridae
has been documented, to date there is no published
report on IRF activities in BTV infection.
In this study, we have examined the interrelationship
between the intrinsic and extrinsic pathways of apopto-
sis in BTV infected cells and demonstrated that the
intrinsic and extrinsic apoptotic pathways are indepen-
dently triggered, and a second executioner caspase, cas-
pase-7, is activated. The role of apoptosis or necrosis in
the development of BTV pathogenesis is currently not
determined, however, it has been suggested by some
that it is due to cell necrosis [6] while others believe
that cell apoptosis is the major cause for the disease [9].
The data that we obtained here demonstrates that BTV
infection triggers strong apoptotic response indicating
that it has some role in the disease. Since translocation
of high mobility box group-1 (HMBG-1) from nucleus
to cytoplasm is a distinct feature of necrosis, we exam-
ined if HMBG-1 was translocated during BTV infection
[20-22]. The data demonstrated that HMBG-1 was not
translocated from the nucleus thereby indicating that in
cell culture apoptosis is the predominant cause of cell
death. We also present evidence that NF-B, although is
activated, is unlikely to be responsible for BTV apopto-
sis. Indeed both BTV replication and cytopathic effect
are enhanced in the presence of a chemical inhibitor of
NF-B activation. These results suggest that NF-B acti-
vation may be involved in the development of the cyto-
kine response. In addition, we observed that IRFs,
particularly IRF-3, were up-regulated during BTV infec-
tion. Thus, it is likely that BTV infection triggers the
NF-B and IRF activations to establish an antiviral state
in order to control BTV replication.
Results
Activation of cellular caspases in BTV infected cells
Previous reports from our laboratory and by others have
demonstrated that caspase -3, -8 and -9 are activated
during infection with BTV [9-12]. To further characterise
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the activation of apoptotic pathways during BTV infec-
tion, HeLa cells were infected with BTV-1 and activation
of caspase-3, -8 and -9 were monitored by western
immunoblot analyses. Activation of all three caspases, as
expected, was observed during BTV infection in both cell
types (Figure 1). Caspase-3 is one of the executioner
molecules of the caspase cascade that leads to apoptosis.
The cleavage of the full-length 35 Da procaspase-3 to
produce the active 17 Da caspase-3 product was
detected after 24 h post infection (p.i.) in BTV infected
Figure 1 Activation of apoptosis by intrinsic and extrinsic pathways in BTV infected mammalian cells. A: Detection of cleavage of
caspase-3 in BTV-1 infected HeLa cells at different times p.i. B: Immunofluorescence of BTV-1 infected HeLa cells shows the morphological
changes associated with apoptosis. (a) Uninfected cells stained with Hoescht, (b) BTV-1 infected stained with Hoescht, the nuclear blebbing and
condensation is indicated by a white arrow, (c) BTV-1 infected stained with Hoescht (blue) and immunofluorescence detection of VP5 (green)
and (d) BTV-1 infected stained with Hoescht (blue), VP5 (green) and caspase-3 (red) detected by immunofluorescence. BTV infected HeLa cells
undergoing apoptosis are indicated by the open arrow and uninfected cell indicated by the closed arrow. (e) Uninfected HeLa cells and (f) BTV-1
infected HeLa cells stained with Hoescht (blue) and anti-active caspase-8 monoclonal clonal antibody (red). Cleaved caspase-8 is visible in the
BTV infected cells (open arrow) C: Detection of caspase-8 cleavage in BTV-1 infected HeLa cells at different time p.i. The procaspase-8 (43 kD),
cleaved caspase-8 (18 kDa) product and a 26 kDa non-specific band (*) are indicated. D: Detection of cytochrome C (12 kDa) in the
mitochondrial (top) and cytosolic (bottom) fractions of BTV-1 infected cells at different times post infection, demonstrating the release from the
mitochondria and its accumulation in the cytosol. E: Western immunoblot analysis of caspase-9 cleavage in the whole cell lysate of BTV-1
infected cells. The procaspase-9 (47 kDa) and cleaved (37 kDa) products of caspase-9 are indicated.
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mammalian cells, and was continually detected over the
time course of infection (Figure 1A). To substantiate the
biochemical data, BTV-1 infected HeLa cells were fixed
at 24 h p.i. and stained with Hoescht in order to visualise
the morphological changes in infected cells (Figure 1B).
Distinct chromatin condensation and nuclear fragmenta-
tion were observed in BTV infected cells (Figure 1B, a)
indicating signs of apoptosis. There was no condensation
or fragmentation in the nucleus of the uninfected control
cells (Figure 1B, b). To confirm that morphological
changes were specific to BTV infected cells we performed
immunofluorescence, anti-VP5 antibody was added onto
the infected cells after permeabilisation and cells were
stained with Hoescht. The results showed early stages of
nuclear condensation and fragmentation in BTV infected
cells (Figure 1B, c), and not in the bystander uninfected
cells in the same sample. Further, dual labelling of
infected cells with anti-VP5 antibody and anti-caspase-3
antibody confirmed that apoptosis occurred in infected
cells, whilst none of the bystander cells showed any signs
of apoptosis (Figure 1B, d).
Previously, we have demonstrated that treatment of
mammalian cells with only the two outer capsid pro-
teins (VP2 and VP5) resulted in the induction of apop-
tosis, which led us to hypothesise that the virus
attachment proteins trigger apoptosis via the extrinsic
pathway. To investigate the role of the extrinsic pathway
in triggering BTV apoptosis, we examined the cleavage
of caspase-8. Whole cell lysate from BTV infected cells
was monitored for the cleavage of caspase-8 by western
immunoblot. The 18 kDa cleavage product was observed
from 12-14 h onwards and reached a maximum at 16 h
p.i. (Figure 1C). To further investigate that caspase-8
was active, we performed immunofluroscence micro-
scopy assay using a specific antibody that recognises the
active caspase-8 protein. HeLa cells infected with BTV
at a low MOI were fixed at 24 h p.i. with paraformalde-
hyde, permeabilised and treated with anti-caspase-8 fol-
lowed by anti-rabbit Alexa Fluor 488. The active form
of caspase-8 was observed only in the cells infected with
BTV and not in the control uninfected cells (Figure 1B,
e &1B, f).
In the intrinsic pathway, apoptosis is triggered by
internal signals leading to leakage of the outer mito-
chondrial membrane, which causes the release of cyto-
chrome C into the cytoplasm. We examined if BTV
infection causes mitochondrial damage and the release
of cytochrome C. Both cytosol and mitochondria frac-
tions of BTV-infected HeLa cells were examined at dif-
ferent times by western analysis, using anti-cytochrome
C polyclonal antibody. As shown in Figure 1D, the cyto-
chrome C was detected in the cytosol as early as 2 h p.i.
and by 8 h p.i. it was translocated entirely to the cytosol
from the mitochondria. To determine further the
activation of the intrinsic pathway by BTV infection, the
cleavage of procaspase-9 to the active form was exam-
ined. The 47 kDa procaspase-9, which mediates the acti-
vation of apoptosis via the mitochondrial pathway, was
cleaved to the activated 35 kDa fragment after 8 h p.i.
(see Figure 1E). The release and timing of cytochrome C
depletion from the mitochondria coincided with cas-
pase-9 activation. This would indicate that the release of
this protein from the mitochondria into the cytoplasm
was due to the BTV-induced apoptosis.
As the cleavage of caspase-8 and caspase-9 occurred
at similar times p.i., we examined whether the mito-
chondrial damage and subsequent release of cytochrome
C into the cytosol could also be mediated by the clea-
vage of BID (a death agonist member of the Bcl2/BclxL
family; [23,24]) via caspase-8 activation. This would
indicate that there is a cross-talk between the intrinsic
and extrinsic pathways. The truncated BID (tBID) pro-
duct was not detected in any of the BTV infected cells
by western analysis (data not included). Thus, caspase-9
activation is likely to be independent of caspase-8. The
accumulated data suggests that both the intrinsic and
extrinsic pathways are activated and the intrinsic path-
way is independent of the extrinsic pathway in BTV
infected mammalian cells.
Caspase activations by intrinsic and extrinsic pathways
are independent in BTV infection
The interrelationship between the intrinsic and extrinsic
pathways and induction of BTV dependent apoptosis
was further investigated using specific chemical inhibi-
tors for each caspase-3, -8 and -9 activities at different
concentrations. The ability of the chemical inhibitors to
interrupt the activation of caspase-3 after BTV infection
was monitored. HeLa cells were treated with various
chemical inhibitors of caspases 1 h prior to BTV infec-
tion, harvested at 24 and 48 h p.i. and whole cells
lysates were analysed for the cleavage of caspase-3
(Figure 2A). Since caspase-3 cleavage was observed from
24 h p.i. onwards (see Figure 1), earlier time points were
not monitored. Both control uninfected and BTV
infected cells were also grown in the presence of DMSO
as used for the inhibitors. The cleavage of procaspase-3
(35 DA) was delayed in the presence of caspase-3 spe-
cific inhibitor (Z-DEVD-FMK, Figure 2A, i) as expected,
and at the highest concentrations of the inhibitor, the
cleavage was not observed at 24 h p.i. In contrast, in the
absence of the inhibitor, procaspase was cleaved and the
17 DA cleavage form at 24 h p.i. was clearly identified
by western blot (Figure 2A, i). Caspase-3 cleavage was
also detected in BTV infected HeLa cell samples that
had been treated with either Z-IETD-FMK (specific
capase-8 inhibitor) or Z-LEHD-FMK, (specific caspase-9
inhibitor) at 24 and 48 h p.i (Figure 2A, ii &2A, iii).
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There was no apparent difference in the cleavage of
caspase-3 in BTV infected cells in the presence or
absence of either the caspase-8 or caspase-9 specific
inhibitors. These inhibitor studies further support the
independent activation of both intrinsic and extrinsic
pathways of apoptosis by BTV infection.
Since there are contradictory reports regarding the acti-
vation of caspase-8 in bluetongue infections [10,12,25], we
determined if caspase-8 activity was present independently
of caspase-9 activity during BTV infection. Western analy-
sis of BTV infected cells showed the cleaved products of
the activated caspase-8 in infected cells treated with the
caspase-9 inhibitor (Z-LEHD-FMK; Figure 2B). At 24 h
p.i. cleavage of caspase-8 was observed in the presence of
Z-LEHD-FMK inhibitor at all concentrations tested. There
was no cleavage in the 48 h p.i. samples, which is consis-
tent with the control BTV infected cells. The data added
further support to the notion that the pathways are inde-
pendent in BTV infection.
To substantiate the data obtained with chemical inhi-
bitors, we infected a caspase-9 deficient cell line (Jurkat
ΔC9) with BTV and monitored caspase 3 cleavage. The
35 kDa procaspase-3 is cleaved in the BTV infected Jur-
kat ΔC9 from 48 h p.i. (Figure 2C). This antibody is
Figure 2 Cleavage of caspase-3 by BTV-1 infection either in inhibitor-treated cells or in knock-out cells. A: Immunoblot of Caspase-3
using anti-caspase-3 polyclonal antibody (Abcam: ab17819). B: The cleavage of caspase-8 in caspase-9 inhibitor (z-LEHD-FMK) treated cells
infected with BTV-1. The 18 kDa cleaved product and a 26 kDa non-specific band (*) are indicated. C: Immunoblot of capase-3 cleavage
products at different times of BTV-1 infection in caspase-9 deficient Jurkat T-cells (JurkatΔC9) and complemented caspase-9 deficient Jurkat
T-cells (Jurkat compΔC9) using an alternate anti-caspase-3 polyclonal antibody (Abcam: ab90437). Representative results from three independent
experiments are shown.
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specific for the procaspase but not the cleaved product.
There was a slight delay in procaspase-3 cleavage in the
complemented-Jurkat ΔC9 with cleavage observed at 72
h p.i. The results were consistent with the pharmacolo-
gical data demonstrating that caspase-3 could still be
activated in absence of caspase-9 activation (Figure 2C).
Thus, both pathways are activated during BTV infection
but are not dependent on each other.
Caspase-7 is activated during BTV infection
Caspase-8 and -9 are not only responsible for the clea-
vage of caspase-3, but also cleave caspase-7. We exam-
ined if caspase-7 was also cleaved in BTV infected cells.
Jurkat T-cells were infected with BTV-1, and cell lysate
harvested at various times were subjected to western
analysis. The 35 kDa procaspase-7 was clearly visible in
the control, uninfected cells, but was not detectable in
BTV infected cells at 16 h p.i. (Figure 3A). Distinct clea-
vage and reduction of the procaspase-7 form were also
evident in the positive control cells that were treated
either with chemical inducers staurosporin or with
etopside at 8 h and 16 h post-treatment, respectively
(Figure 3A). The use of a second executioner caspase
indicates that BTV induces a robust apoptotic response
in infected cells.
BTV-1 infection induces the caspase-dependent cleavage
of PARP
The executioner caspases-3 and -7 initiate the later
stages of apoptosis by inactivating key host cell proteins
including PARP (poly (ADP-ribose) polymerase), which
is involved in DNA repair.
Inactivation of PARP by cleavage results in DNA frag-
mentation. We investigated if PARP is also cleaved dur-
ing BTV infection. Mammalian cells were infected with
BTV-1 and PARP cleavage was monitored at different
times post-infection by western analysis using specific
antibody (Figure 3B). The full-length 116 KDa PARP
could be detected from all samples at 0 to 16 h p.i. in
BTV infected cells, and the 85 kDa cleavage product was
detectable from 24 h p.i. onwards (Figure 3B). In contrast
to BTV infection, a chemical inducer of PARP (DOX,
Doxorubicin) induced the cleavage of PARP in the cell
culture as early as 16 h after its addition (Figure 3B).
As cleavage of PARP occurs only in apoptotic cells
and to further support the notion that BTV infection of
Figure 3 BTV causes an apoptotic response in preference to a necrotic response in mammalian cell culture. A: The detection of a
second executioner, caspase-7, in BTV-1 infected cells. Whole cell lysate extracts were prepared from different times post infection and
monitored for caspase-7 cleavage with a specific anti-caspase-7 polyclonal antibody. B: Detection of caspase-dependent PARP cleavage in BTV
infection by immunoblot at different times p.i. Cleavage of the PARP from the full length (116 KDa) to inactive cleaved form (85 kDa) is observed
in the BTV infected and DOX treated cells and not the control uninfected. C: Detection of HMGB-1 (26 kDa) by immunoblot in the nuclear (left)
and cytosolic (right) fractions of HeLa cells that were uninfected (1), DOX-treated (2) and BTV-1 infected (3).
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mammalian cells primarily results in apoptosis rather
than necrosis, the translocation of HMBG-1 protein
from the nucleus to the cytoplasm was investigated.
HMBG-1 translocation is considered to be an indicator
of a necrotic state rather than an apoptotic state of the
cells [26]. BTV infected cells were harvested at 24 h p.i.
and the cytosolic and nuclear fractions were separated
and analysed by western analysis. It was clear that
HMBG-1 was retained in the nuclear fraction and there
was no detectable translocation of the protein to the
cytosolic fraction during BTV infection (Figure 3C).
NF-B has a limited role in BTV induced apoptosis
NF-B is generally involved in cellular responses not
only to stress, injury and cytokines but also to virus
infection. In particular, it plays a key role in regulating
the innate immune responses to virus infection. Conver-
sely, it may also be involved in triggering inflammation
and cell death (i.e., apoptosis). Thus, it controls the bal-
ance between cell survival and death. We have shown
previously that NF-B is translocated to the nucleus
during BTV infection [11] indicating that BTV infection
causes the activation of the NF-B complex and
hypothesised that it might be involved in inducing apop-
tosis similar to reoviruses [13]. Therefore, we investi-
gated whether activation of NF-B in BTV infection is
indeed involved in the induction of apoptosis. HeLa
cells were treated with 32 μM NF-B inhibitor (SN50)
for 60 min prior to infection with BTV and cell mor-
phology was monitored by light microscopy. Typical
BTV induced cytopathic effect was observed in cells
treated with SN50 at earlier time points (24 h p.i.,
Figure 4A) in comparison to the normal BTV infection
(48 h p.i., Figure 4A). The visible cytopathic effect
observed in the treated and untreated BTV infected cells
would indicate that NF-B is not involved in the mor-
phological changed induced by the virus. To further
examine if NF-B is involved in the induction of apop-
tosis, we tested the cleavage of caspase-3 in the presence
of SN50 during BTV infection. There was no significant
difference in the caspase-3 cleavage activity of BTV-1
infection between the SN50 treated versus the untreated
cells (Figure 4B). These results indicate that NF-B
response to BTV-1 infection is probably similar to type
1 reovirus strain Lang (T1L, [27]), where NF-B activa-
tion has a minimal role in the induction of apoptosis.
Our data would indicate that NF-B activation in BTV
infected cells is not directly involved in the induction of
apoptosis.
NF-B response is regulated by IkBa degradation during
BTV infection
The response of NF-B during BTV infection was
further characterised. The type of response and
activation of NF-B to an infection is controlled by the
IB complex, which mask the nuclear translocation sig-
nals and act as inhibitor proteins. We investigated the
phosphorylation and degradation of IBa and b in HeLa
cells infected with BTV in order to analyse the NF-B
response. Cell lysates were harvested and subjected to
western blot using specific antibodies for IBa and
IBb. While IBa degradation was clearly detected in
BTV infected cells (Figure 5A), there was no detectable
degradation of IBb (Figure 5B). The phosphorylation
and degradation of the 35 kDa IBa was rapid in the
BTV infected cells and only up to 4 h p.i. IBa could be
observed (Figure 5A), while the chemically (DOX) trea-
ted cells when used as positive controls, showed a simi-
lar pattern of degradation to that of BTV infection (data
not shown). There was no degradation of IBa in the
uninfected cells (Figure 5A). In contrast, IBb subunit
degradation was not observed in the BTV-1 infected
samples at the time points monitored (Figure 5B). Such
selective degradation of IBa, but not IBb by BTV
infection means that it triggers the typical rapid
response of NF-B in mammalian cells rather than a
persistent activation. The results indicate that the nature
of the NF-B response may be rapid.
Activation of NF-B response is early during BTV
infection
The degradation of IBa and translocation of the NF-B
into the nucleus during BTV infection prompted us to
investigate the level of NF-B activation using a NF-B
dependent luciferase reporter gene system. Up-regulation
of the NF-B dependent transcripts was detected in BTV
infected cells from 4-8 h p.i. (Figure 6A). When relative
light units of firefly luciferase (RLU) activities were nor-
malised from three different experiments, there was clear
indication of ~2-3 fold NF-B activation in BTV infected
cells in comparison to that of the controls, (uninfected
cells, Figure 6A). However, after the peak activation at 8
h p.i., the activity was effectively suppressed. The NF-B
response for all experiments showed a similar pattern.
Furthermore, when SN50 inhibitor treated cells were
infected with BTV, the RLU at each time point was lower
in comparison to the uninfected cells (Figure 6A). The
data indicated that although NF-B is active during BTV
infection, the response is early and transient.
BTV-1 proteins can suppress the activation of NF-B
signal pathway
Since the NF-B dependent reporter gene assay indicated
the suppression of the NF-B activation by BTV replica-
tion, we undertook a preliminary study to examine the
involvement of each viral protein in NF-B activation. In
order to measure the effect of the newly synthesised indi-
vidual proteins on the induction or suppression of the
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NF-B response, HeLa cells were co-transfected with the
NF-B dependent reporter plasmid together with various
BTV mRNAs, S2 (VP2), S4 (VP4), S5 (NS1), S8 (NS2), S9
(VP6) and S10 (NS3) that were synthesized from exact
copy T7 vectors as described in Materials and Methods.
The transcripts were co-transfected with the reporter
plasmid to reduce the effect of mRNA triggering NF-B
response. NF-B activation was induced with poly I:C
Figure 4 Inhibition of NF-B with SN50 inhibitor does not prevent apoptosis in BTV infected cells. A: Morphological changes associated
with BTV infection in the presence or absence of SN50 inhibitor at different times p.i. BTV infected cells and uninfected cells without the
inhibitor and BTV infected cells and uninfected cells in the presence of the SN50 inhibitor are also shown. B: NF-B induction by BTV-1 infection
of mammalian cells does not influence the cleavage of caspase-3. Immunoblot analysis of BTV-1 infected, BTV-1 infected that had been pre-
treated with 32 uM of SN-50 inhibitor, uninfected and poly I:C treated HeLa cells was undertaken on whole cell lysate at different times p.i and
the cleavage of caspase-3 detected with rabbit anti-caspase-3. The cleaved 17 kDa product is shown.
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and the firefly luciferase activity was measured at 6 and
24 h time intervals post-induction. To ensure that the
mRNA did not induce a response and that the suppres-
sion of poly I:C inducted NF-B response was BTV spe-
cific, we used a T7 generated Renilla luciferase mRNA as
a control since the protein can be distinguished from the
firefly luciferase. At 6 h post-induction, only NS1 and
NS2, but not NS3 or the structural proteins had an inhi-
bitory effect on the poly I:C induction of NF-B response
(Figure 6B). At 24 h post-induction of NF-B by poly I:C,
the suppressive effect of the NS1 diminished with an
increase in the RLU, in comparison to the NS2 sample,
which only had a slight increase in the RLU measure
(Figure 6B). This indicates that both NS proteins have a
role in controlling the NF-B response to BTV infection.
NF-B activation controls early virus replication in
mammalian cells
The accumulated data so far indicates that NF-B acti-
vation in response to BTV infection is an early and tran-
sient response and appears to have a minimal role in the
induction of apoptosis. Therefore, we wanted to exam-
ine if it was involved in limiting virus replication. Cells
were treated with 32 μM SN50 inhibitor prior to infec-
tion with BTV-1 (~0.1-0.5 MOI) and the virus titres at
various times were determined by tissue culture infec-
tious dose of 50% (TCID50/ml). During the early phase
of virus growth (8, 12 and 16 h p.i.), there was a mini-
mal difference in the virus titres between the SN50 trea-
ted and untreated cells (Figure 7). However, at 24 h p.i.,
a significant difference was detected in the virus titres
Figure 5 BTV-1 infection of HeLa cells leads to the degradation
of IkBa and not IkBb. Whole cells fractions from HeLa cells
infected with BTV-1 (MOI-1) at different times p.i. were analysed by
immunoblot using specific antibodies A: IkBa immunoblot of BTV-1
infected cells and uninfected cells at different times p.i. B:
Immunoblot of IkBb in BTV-1 infected and control uninfected cells.
Figure 6 BTV-1 infection of HeLa cells activates NF-B
response. A: HeLa cells were transfected either pGL3Basic luciferase
control or pGL3NFB luciferase and infected with BTV-1 (MOI 0.5-1)
or treated with DOX and analysed for luciferase activity (RLU).
Normalised RLU values for the control uninfected (grey), DOX
treated (white), BTV-1 (black) and BTV-1 in the presence of SN50
inhibitor (black-lined) at different time points (0 h-16 h) are shown.
B: Expression of luciferase (RLU) from an NF-B dependent
luciferase reporter in the presence of individual BTV proteins after
induction with poly I:C assay at two different times, 6 h (a) and 24 h
(b). The normalised RLU was measured in uninduced (white) and
induced (black) and the fold induction (<0 = suppression, 0 = no
change, >0 = induction) was calculated as indicated. This is a
representative experiment and the data presented is normalised
from 3 different tests.
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between the untreated versus the inhibitor treated cells.
In the presence of the inhibitor, virus titres were signifi-
cantly higher (p > 0.1, 2 replicates repeated duplicate by
TCID50/ml). This effect is diminished at the 48 h and
yielded very similar titres in both treated and untreated
cells (Figure 7). This would be consistent with the
observation that BTV and some of the virus proteins
specifically suppress the NF-B at later times p.i. to
enable efficient virus progeny to be produced. The
BTV-1 titres were consistently higher when the virus
was grown in the presence of the SN50 inhibitor, which
further supports our hypothesis that during BTV infec-
tion of mammalian cells, NF-B activation aims to sup-
press replication of the virus. This observation together
with the other data that we obtained indicates that the
main role of NF-B during BTV infection is to suppress
virus replication.
Interferon regulatory factors are up-regulated during
BTV-1 infection
The results so far indicate that the role of NF-B during
BTV infection probably relates to induction of an antiviral
state of infected cells. Indeed, it has already been docu-
mented that BTV causes a strong cytokine response dur-
ing early infection both in vivo and in vitro [5-7,9,28,29].
Infection by viruses or transfection with dsRNA results in
rapid induction of type 1 IFN that establishes the innate
immune response and requires multiple transcriptional
proteins [30]. Since the interferon regulatory factor-3
(IRF-3) contributes to a first line of defence against virus
infection, we investigated whether the BTV infection of
mammalian cells results in the activation of IRF-3 and
related IRF-7. HeLa cells were infected with BTV, and
samples from whole cell lysate and cell fractions were har-
vested at different times p.i. and subjected to western ana-
lysis. Translocation of IRF-3 into the nucleus of BTV
infected cells was detected after 8 h p.i. (Figure 8A, a). The
up-regulation and translation of IRF-7 in response to
BTV-1 infection of HeLa cells was observed in the whole
cell lysate at 16 h p.i. (Figure 8A, a).
The activities of IRF-3 and -7 by BTV were further
verified using an IRF dependent firefly luciferase repor-
ter gene system to measure the activation as described
for the activation of NF-B above. The data was nor-
malised from at least 3 independent replicates. The fire-
fly luciferase RLU values in BTV infected cells at 8 h p.i
were higher than both controls, the poly I:C transfected
and the uninfected cells (Figure 8B). Activation of the
IRF-dependent reporter by BTV infection had a peak
activity at 8 h and greater than 2-fold increase from the
uninfected control cells (Figure 8B). The IRF response
to BTV infection followed a similar trend for all experi-
ments undertaken. The poly I:C strongly activated the
IRF dependent reporter as expected (Figure 8B).
Virus proteins play a role in limiting the induction
of IRF response
The response observed from the IRF dependent luciferase
activity during BTV infection demonstrated similar
kinetics to the NF-B dependent firefly luciferase activity
and therefore it is likely that de novo synthesis of intracel-
lular BTV proteins play a role in limiting the IRF response.
An experiment analogous to the NF-B, using T7 mRNA
for various BTV proteins together with an IRF dependent
firefly luciferase report construct was undertaken to deter-
mine if the IRF response was indeed controlled by newly
synthesised BTV proteins when induced with poly I:C.
Interestingly, at 6 h post-transfection, unlike the NF-B
response, not only did all the three NS proteins, but also
the major outer capsid protein VP2 had an effect on the
poly I:C induced IRF activity (Figure 8C) in comparison to
the expressed Renilla lucerifase control. The two internal
catalytic proteins, VP4 and VP6, failed to reduce the poly
I:C induced IRF response. At 24 h post-induction, only
NS1 and NS2 had some inhibitory effect, while an increase
in RLU was observed for VP2 (~1.3 fold) and NS3 (~7
fold). These results suggest that with the increase of BTV
proteins synthesis, activation of IRF decreases in order to
allow BTV replication.
Figure 7 Replication of BTV-1 in HeLa cells in the presence of
a NF-B inhibitor. BTV growth in the presences of 32 μM NF-B
inhibitor (□) and mock treated (◆) HeLa cells at different times p.i
was determined by TCID50/ml using Muench and Reed method.
Representative data from two independent assays undertaken in
triplicate is presented.
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Discussion
The infection of mammalian cells by many viruses
induces apoptosis and a variety of signal transduction
pathways either to promote cell survival or to enhance
the cell death. BTV infection of mammalian cells also
triggers apoptosis. There are two common pathways for
the induction of apoptosis and it appears that BTV may
trigger both intrinsic and extrinsic pathways [9-12]. The
extrinsic pathway is primarily initiated by virus attach-
ment to receptors, while the intrinsic pathway is
mediated by damage to the mitochondria. In this report,
we have undertaken a series of stepwise experiments to
examine the cellular activations of various caspases and
thereby induction of apoptosis during BTV infection.
Figure 8 BTV-1 infection of HeLa cells activates an IRF response. A:Nuclear translocation of IRF-3 (a) and IRF-7 up-regulation (b) in BTV-1
infected HeLa cells were detected by immunoblots at different times p.i. B: HeLa cells were transfected with IRF dependent firefly luciferase
reporter and infected with BTV-1 (MOI 0.5) or transfected with poly I:C and analysed for luciferase activity (RLU). Normalised data for the control
uninfected (grey), poly I:C treated (white), and BTV-1 infected (black) at 4 different times are shown. C: Expression of luciferase (RLU) from an IRF
dependent firefly reporter in the presence of individual BTV proteins after induction with poly I:C at two different times, 6 h (a) and 24 h (b). The
normalised RLU for each protein in induced (black) and uninduced (white) samples and the fold induction (< 0 = suppression, 0 = no change,
>0 = induction) are shown. This is a representative experiment and the data presented is normalised from 3 different tests.
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Further, we investigated if the caspase activities via
intrinsic and extrinsic pathways during BTV infection
are interdependent. Data obtained in this report conclu-
sively confirmed the activation of caspase-8 in BTV
infected cells by two different methods. The cleavage of
caspase-8 was observed from 12 h p.i. by western analy-
sis and the active, cleaved form was visualised by confo-
cal microscopy. As the primary activation of caspase-8 is
due to receptor binding, it was expected that caspase-8
activation would occur relatively early after infection
with BTV. However, we noted that the caspase-8 activa-
tion in BTV infection was somewhat delayed compared
to other viruses (e.g., reoviruses). Although we have not
investigated further, it can be hypothesised that it is
regulated by c-FLIP, an apoptosis inhibitor, as in reo-
virus infection [27]. The control of caspase-8 by c-FLIP
could be regulated by the activity of MAPK p38 [31,32],
which has been shown to play a role in BTV-induced
apoptosis and endothelial damage [33,34].
Our data also demonstrated the involvement of the
intrinsic pathway in BTV infection as documented by
the disruption of the mitochondria and release of cyto-
chrome C which is known to be responsible for activat-
ing a number of events that leads to the cleavage of
caspase-9. Thus, our data supports the recent report
that cytochrome C is released from the mitochondria
during an early stage of the BTV replication cycle [10].
The direct evidence of caspase-9 cleavage was confirmed
by western analysis. Moreover, the timing of mitochon-
drial damage precedes the cleavage of caspase-9 as pre-
sented in this report. Although the activation of an
apoptotic response by the initiator caspase-8, -9 and
executioner caspase-3 in response to BTV replication
has been reported previously, to date the relationship
between the two pathways remains unknown.
In this study, the relationship between the intrinsic
and extrinsic pathways was determined using a series of
assays including cell markers, pharmacological inhibitors
and knock-out cell lines. Unlike reoviruses [35], there
was no cleavage of BID by caspase-8 in BTV infected
cells. Therefore, the extrinsic pathway is unlikely to
induce the mitochondrial damage as observed in our
studies. Furthermore, the use of a chemical inhibitor
and the caspase-9 deficient cell line (Jurkat ΔC9) clearly
confirmed that caspase-8 activation was also indepen-
dent of caspase-9 during BTV infection of mammalian
cells. Thus, the activation of each caspase pathway dur-
ing BTV-1 infection appears to be independent.
In addition to the activation of executioner caspase-3,
we found that BTV infection also induces the activation
of caspase-7, another executioner caspase which is clo-
sely related to caspase-3, sharing similar structure and
substrates, but less promiscuous [36]. Caspase-3 and -7
share a number of target proteins and both recognise
caspase death substrate PARP. We investigated PARP
cleavage in BTV infection and the cleavage of PARP was
detected in response to BTV infection of mammalian
cells, adding further support that BT clinical signs are
mainly mediated by apoptosis.
DeMaula et al. [5,6] have hypothesised that the main
component of BT clinical signs and lesions in endothe-
lial cells is due to cellular necrosis. Their hypothesis was
based on the observation at the late stage of BTV infec-
tion. In this study, we examined cellular necrosis by
using a cellular marker HMGB-1. When necrosis is
induced it causes the loss of cellular membrane integrity
and HMGB-1 is translocated from nucleus to cytoplasm
and rapidly released into the extracellular space, which
results in inflammation and tissue damage [22,37,38].
When we examined the cytosolic and nuclear fractions
of BTV infected HeLa at 48 h p.i., there was no HMGB-
1 translocation to the cytosol. Therefore, the cell death
and damage observed in BTV infection of mammalian
cells is not due to necrosis but probably due to the very
late timing of events and the cell disruption caused by
the inflammatory response.
The data presented in our paper demonstrates that BTV
infection of mammalian cells induces caspase cascade,
resulting in apoptosis. These results indicate that apoptosis
is a major cause of cellular damage in the host animal,
supporting previous reports [9,12]. However, it will be
imperative to investigate the caspase activation and the
role of apoptosis in BT disease in susceptible sheep.
Previously, we reported the activation of NF-B in BTV
infected cells [11] and hypothesised that it has a role in
BTV-induced apoptosis similar to that of reovirus T3
[13]. However, here we found that the inhibition of NF-
B had no effect in virus-induced apoptosis. Indeed, our
data clearly demonstrated that chemical inhibition of the
p50 subunit of NF-B enhanced the early onset of visible
cytopathic effect in BTV infected cells, and thus contra-
dicted the report of Mortola and Larsson [25].
Therefore, it was necessary to further investigate the
response of NF-B to BTV infection. The type of
response by NF-B is related to the phosphorylation
and degradation of the IB complex, an inhibitory pro-
tein complex, which masks the nuclear translocation sig-
nal of NF-B. Our data showed the degradation of IBa
but not IBb in response to BTV infection, which indi-
cates that the classical NF-B pathway is activated
resulting in a controlled transient response. Further-
more, we examine the activation of NF-B by using a
NF-B dependent firefly luciferase reporter assay. Our
data showed an initial early period of NF-B activation
that was not sustained, as the NF-B activity appeared
to be inhibited at later stages of virus replication. The
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NF-B response observed by BTV infection was similar
to that of the T3 strain of reovirus [39].
From our preliminary data, we postulate that the tran-
sient nature of the NF-B response was due to BTV
proteins suppression of NF-B activation, which in turn
allowed efficient virus replication. BTV NS1 and NS2
limited NF-B activation when the response was stimu-
lated by poly I:C. Both of these proteins have the ability
to bind RNA and therefore could act by sequestering
dsRNA and inhibiting the pathway, or could interact
with cellular proteins to inhibit the cascade (i.e. rota-
virus [40]), or inhibit mRNA export from the nucleus
(i.e. rotavirus NSP3 [41]).
Thus, our data showed that activation of NF-B by
BTV infection had a minimal role, if any, in the induction
of apoptosis. However, it may play a role in initiating an
antiviral state through the induction of the innate
immune response. To this end, we investigated the effect
of NF-B activation on BTV replication and generation
of infectious virions. In the presence of an NF-B inhibi-
tor, BTV titres were higher at the early stages (up to 24 h
p.i.) of virus replication than in the absence of inhibitor.
This result would indicate that NF-B activation acts to
control virus replication. At the late times, virus titres
were similar in both cases, which could be indicative of
the virus proteins controlling the NF-B response (i.e.
NS1 and NS2). The induction of NF-B response in con-
trolling virus replication through the induction of an
antiviral response needs to be investigated further, espe-
cially as a recent report demonstrated that BTV replica-
tion was significantly high in IFNa deficient mice
resulting in rapid death of these animals [42].
BTV infection has been reported to produce strong
cytokine responses [7,43-45], however the mechanisms
that trigger their production has not been investigated.
NF-B activation could be a candidate to initiate a cyto-
kine response during BTV infection, although there
are other pathways, including IRF that could induce cyto-
kine response. In this report we were able to identify
the translocation of IRF-3 to the nucleus in response to
BTV infection, indicating the induction of IRF-3 by BTV
infection. As well as IRF-3, which is sequestered in the
cytosol, the production of IRF-7 and its subsequent
translocation to the nucleus were also detectable in BTV
infected cells. Moreover, using an IRF dependent firefly
luciferase reporter assay we confirmed that IRF activation
was stimulated during BTV infection. Interestingly, the
kinetics of IRF activation mirrored NF-B activation.
This early response of IRF was suppressed over the
course of BTV infection similar to that of NF-B. Despite
the activation of IRF and NF-B, it is clear that BTV
infection triggers robust apoptosis in mammalian cells,
which most likely play a role in BTV pathogenesis.
Materials and methods
Cells, viruses and antibodies
Human cervical epithelial carcinoma (HeLa) and BSR cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM; Lonza) supplemented with 10% fetal calf serum
(FCS), 100 U/ml penicillin and 100 mg/ml of streptomycin
(Lonza) and incubated at 35°C, with CO2. Jurkat T-cells
were purchased from ATCC and caspase-9 deficient Jurkat
T-cells (Jurkat ΔC9) and complemented caspase-9 Jurkat
T-cells (Jurkat compΔC9) were kindly provided by Klaus
Schulze-Osthoff (University of Dusseldorf, Germany). The
cells were grown in RPMI media (Sigma Aldrich) supple-
mented with 6% FCS, 100 U/ml penicillin and 100 mg/ml
of streptomycin (Lonza) and incubated at 35°C, with CO2.
BTV serotype 1 (BTV-1) was titred by plaque assay as
described [46] and multiplicity of infections (MOI)
between 0.1 and 1. For all experimental infections, cell
monolayers were washed with FCS free growth medium,
incubated with BTV-1 at the appropriate MOI in
serum-free medium for 30 mins, the virus inoculums
were aspirated, the cells washed twice in excess DMEM
and further incubated in DMEM supplemented with 2%
FCS and 100 U/ml penicillin and 100 mg/ml of strepto-
mycin for the time course of the experiment. The proce-
dure was similar for the infection of Jurkat T-cells with
the exception that RPMI media was used.
Antibodies for detection of the caspase-8 (ab25901), cas-
pase-9 (ab25758), caspase-3 (ab17819; ab90437) and anti-
HMGB were purchased from Abcam. Active caspase-8
(18C8 #9496), caspase-9 (#9501) and caspase-7 (#9492)
antibodies were purchase from Cell Signaling. Antibodies
to detect the cellular proteins (tubulin and actin; AC-15),
caspase-3 (clone 4H334) and PARP (clone C-2-10) were
purchased from Sigma Aldrich. Specific antibodies for
BTV were generated in house. Inhibitors of caspase clea-
vage were purchased from Calbiochem and Sigma Aldrich.
Anti-IkBa (E:130), anti-IkBb (ab7547), anti-NF-B (p50/
p105) and anti-NF-B (p65) polyclonal antibodies were
purchased from Abcam. Inhibitor of NF-B (SN50; Cal-
biochem) was resuspended in distilled water was used at
final concentration of 32 uM. Anti-IRF-3 (FL-425, sc9082)
and anti-IRF-7 (H-246, sc9083) polyclonal antibodies were
purchased from Santa Cruz.
Alkaline phophatase conjugated secondary antibodies
were purchased from Millipore (mouse) and Sigma
Aldrich (guinea pig and rabbit). Tetramethyl rhodamine
isothiocyanate (TRITC) and fluorescein isothiocyanate
(FITC)-conjugated secondary antibodies were purchased
from Sigma Aldrich.
Preparation of cell lysates for the immunoblot
Whole cells (detached and adhered) were harvested and
rinsed with cold 150 mM phosphate-buffered saline
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(PBS) and resuspended in SDS PAGE lysis buffer and
processed for western immunoblot. For preparation of
different cellular fractions, cells were harvested and
incubated in Hepes buffer, pH 6.8 (10 mM Hepes
10 mM KCl, 1.5 mM Mg2Cl, 340 mM sucrose, 10%(v/v)
glycerol, 0.1%(w/v) Triton X-100, 1× protease-inhibitor
cocktail and 10 μM phenylmethylsulfonyl fluoride
(PMSF) on ice for 30 min and then centrifuged at 4°C,
5 min at 3 000 xg (nuclear fraction). The supernatant
was further centrifuged at 4°C for 45 min at 20 000 xg
to separate the cytosolic fraction from the pellet (mito-
chondria) and the cell extracts were analysed by western
immunoblot.
Western immunoblot analysis
The proteins were resolved on 10-15% SDS-PAGE gels
according to target protein molecular weight, and trans-
ferred to a nitrocellulose membrane (0.45 micron,
Amersham) by the standard semi-dry transfer protocol.
Each blot was developed with specific primary and sec-
ondary antibodies following the manufacturer protocols.
Immunofluorscence by confocal microscopy
BTV-infected cells were fixed with 4% (w/v) paraformal-
dehyde on coverslips, washed in PBS, permeabilised and
blocked as described [47]. Subsequently, cells were
immuno-labelled with primary antibodies, diluted
(1:100-1:200), washed and incubated with appropriate
secondary antibodies conjugated to TRITC (1:64) or
FITC (1:128). Cover slip were mounted in Vectashield
mounting media (Vector Laboratories, Burlingham) and
were examined with a Zeiss Axiovert 200 M laser-
scanning microscope fitted with a helium-argon laser.
Images were acquired and analysed using LSM 510
confocal software (Zeiss).
NFB and IRF dependent luciferase reporter gene assays
The NF-B dependent luciferase reporter plasmid,
pGL3NF-B, was constructed by ligating the 4 repeats
of the of the decameric sequence (GGGAATTTCC)
recognised by NF-B into the Nde1-BglII sites of pGL3
basic luciferase. The IRF dependent luciferase reporter
plasmids were kindly provided by Takashi Futija (Kyoto
University, Japan) and were previously described [48,49].
HeLa cells grown in 96 well plates were transfected
with 0.1 μg/well of the reporter using Lipofecta-
mine2000™ according to manufacturer’s protocols. At 24
h post transfection, cells were either infected with BTV-
1 or transfected with 1 μg/well of poly I:C (Amersham
Pharmacia) using Oligofectamine™ as per manufacturer’s
protocol or treated with 0.6 μg/ml DOX (doxorubicin.
HCl; Sigma Aldrich) or mock infected. Each treatment
was undertaken in triplicates and the assay performed
no less than 5 times. The firefly luciferase activity in
each well was quantified at different times using the
Dual-Luciferase Assay Kit (Promega) to detect both fire-
fly and Renilla luciferase.
For the inhibition assays using NF-B (SN50) inhibi-
tor, cells were transfected with the reporter plasmid
24 h prior to treatment with 32 μM SN50 as above and
then either infected with BTV, or transfected with poly
I:C or treated with DOX.
To study the effect of the BTV proteins on the NF-B
or IRF activation, HeLa cells grown in 96-well plates
were co-transfected with 25 ng of T7 generated BTV
transcripts or Renilla transcript with either the NF-B
or IRF dependent reporter construct using Lipofecta-
mine2000™. T7 mRNA transcripts for VP2, VP4, VP6
and NS1-3 were generated from the BTV-1 exact copy
constructs as previously described [50]. At 24 h post
transfection, the NF-B or IRF response was induced by
transfecting the cells with 1 μg poly I:C. The firefly luci-
ferase activity was measured 6 and 24 h post induction
with the Dual-Luciferase assay kit (Promega).
Virus titration by TCID50/ml
The growth of BTV in the presence of NF-B (SN50)
inhibitor was determined using TCID50 (tissue culture
infectious dose of 50%) endpoint titration. BSR were
grown in 96-well plates and 10-fold serial dilution of the
BTV at different times p.i. were made in DMEM supple-
mented with 2% FCS in replicates of 5. The cells were
fixed with 1% (w/v) paraformaldehyde, CPE was visua-
lised by crystal violet stain and the titre determined as a
TCID50/ml.
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